Diabetics with advancing age accompanying symptoms like high blood pressure, excessive waist fat, and cholesterol imbalance induce poor metabolic control associated with microvascular and microvascular complications. CVD (Cardiovascular disease) threat develops with a mild increase in fasting blood glucose level before it touches to be diagnosed as diabetic.
Obesity: Visceral fat-associated obesity provokes low-grade inflammation in diabetics and raises CVD danger.
Epigenetics: A complex mechanism of connection between histone methylation and DNA causing obesity encourages diabetes-influenced CVD risk.
Inflammation: Overexpression of cytokines caused by adipose tissue and activated macrophages establishes subclinical inflammation in obese diabetics with insulin resistance. Atherosclerosis and CVD develop when these cytokines join chronic inflammatory processes of vessel walls and induce lipid accumulation.
Hyperglycemia: Acute hyperglycemia and glucose fluctuations decrease insulin sensitivity and increase T-cell loss, mitochondrial superoxide production, and endoplasmic reticulum stress by causing glucotoxicity, endothelium-dependent vasodilation, reduced myocardial perfusion, and inflammatory responses.
Hypertension: High blood pressure can be observed before finding hyperglycemia.
Hypertension: Along with diabetes initiates rapid oxidative stress-induced vascular dysfunction and injury.
Dyslipidemia: Diabetics with dyslipidemia show a thermogenic profile consisting of enhanced very low-density lipoprotein cholesterol, triglycerides, and small & dense low-density lipoprotein cholesterol levels & reduced high-density lipoprotein cholesterol levels.
Oxidative stress: Hexosamine and aldose reductase pathways get activated due to increased intracellular glucose concentrations. There is an oxidative load on mitochondria, increased production of reactive nitrogen species, and inflammatory cytokines. Also, there is a formation of advanced end products and the activation of protein kinase. Cumulatively these changes cause an increment in oxidative stress.
Endothelial dysfunction: In diabetics, endothelium-dependent vasodilation disrupts reduced nitric oxide (NO) production from endothelial cells causing increased oxidative stress. Altogether in diabetics, imbalanced NO metabolism leads to microvascular complications.
Cardiovascular autonomic neuropathy: Autonomic imbalance (ANS), inflammation, and CVD erupt in diabetics due to elevated inflammatory markers, increased sympathetic activity, and dysregulation of the autonomic nervous system. ANS destruction causes arterial stiffness, left ventricular hypertrophy, ventricular systolic dysfunction, and modulation of the sinus node, ventricular, and blood vessels.
● Maintain good glycemic control by providing early hyperglycemia treatment associated with metabolic memory protective effects
● Halt obesity by decreasing excessive visceral fat
● Manage dyslipidemia and aggressive atherosclerosis danger
● Control hypertension co-occurrence and cardiovascular morbidity and mortality
● Lower oxidative stress and slow down CVD progression
● Manage epigenetics influence increased body weight and fat level
● Stop inflammatory cascade which promotes cardiovascular imbalance
● Disrupt endothelial dysfunction
● Avoid cardiovascular Autonomic Neuropathy (CAN) manifestation
● Include mandatory screening schedule
● Follow a positive dedicated healthy heart care lifestyle
The key to reducing the burden of diabetes on the cardiovascular system is to identify the optimal time to introduce a suitable combination of personalized approaches & right disease-modifying agents.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Glioblastoma treatment breakthrough shows promise
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Study suggests exercise could reduce breast cancer recurrence
4.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
5.
Daily physical activity, even at light intensities, linked to lower cancer risk
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
3.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
4.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation